Moberg Pharma AB (FRA:MB8) Dividends per Share: €0.00 (TTM As of Mar. 2026)

What is Moberg Pharma AB Dividends per Share?

Moberg Pharma AB FRA:MB8 -2.10% 60 Dividends per Share is €0.00 as of Mar. 2026. GuruFocus rates FRA:MB8 with a GF Score™ of 60/100 and a GF Value™ of €1.06. The stock has 1 warning sign investors should review.

Moberg Pharma AB's dividends per share for the three months ended in Mar. 2026 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00. As of today, Moberg Pharma AB's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Moberg Pharma AB (FRA:MB8) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Moberg Pharma AB's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2026 )	/	EPS without NRI (Q: Mar. 2026 )
	=	0	/	-0.003
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moberg Pharma AB Dividends per Share Related Terms

Moberg Pharma AB Dividends per Share Historical Data

* Premium members only.

The historical data trend for Moberg Pharma AB's Dividends per Share can be seen below:

Moberg Pharma AB Dividends per Share Chart

Moberg Pharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec21

Dec22

Dec23

Dec24

Dec25

Dividends per Share

Get a 7-Day Free Trial

0.00

Moberg Pharma AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Dividends per Share	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

FRA:MB8 vs ZTS, UTHR: Dividends per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moberg Pharma AB Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Dividend Yield % falls into.

Save Embed

60GF Score

Moberg Pharma AB FRA:MB8

Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Moberg Pharma AB Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →

What does a Dividends per Share of €0.00 mean?

Moberg Pharma AB (FRA:MB8) has a Dividends per Share of €0.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Moberg Pharma AB and its competitors.

Is Moberg Pharma AB's Dividends per Share too high?

Moberg Pharma AB's current Dividends per Share is €0.00. Overall, Moberg Pharma AB has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.

How does Moberg Pharma AB's Dividends per Share compare to ZTS and UTHR?

Moberg Pharma AB's Dividends per Share of €0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividends per Share for a Drug Manufacturers company?

A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividends per Share mean?

A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Moberg Pharma AB and its competitors. Moberg Pharma AB's current Dividends per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Moberg Pharma AB stock overvalued right now?

Moberg Pharma AB (FRA:MB8) has a current Dividends per Share of €0.00. The stock's GF Value™ is €1.06, compared to a current price of €0.80 — trading 24.3% below its estimated fair value. The current Dividends per Share is €0.00. Moberg Pharma AB's overall GF Score™ is 60/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividends per Share calculated?

Dividends per Share is calculated from a company's financial statements. For Moberg Pharma AB (FRA:MB8), the current Dividends per Share is €0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moberg Pharma AB (FRA:MB8) Overvalued in 2026?

Based on GuruFocus' analysis, Moberg Pharma AB stock appears to be undervalued. The current stock price of €0.80 is trading 24.3% below its estimated GF Value™ of €1.06.

Key valuation signals for FRA:MB8:

Dividends per Share: €0.00
GF Value™: €1.06 vs. price of €0.80 (24.3% below fair value)
GF Score™: 60/100 with 1 warning sign

No single metric tells the full story. See the FRA:MB8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Moberg Pharma AB Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies OSTO:CINPHA OSTO:ENZY OSTO:NANEXA OSTO:KLAR OSTO:EQL OSTO:DICOT XSAT:ACUC OSTO:VIVE OSTO:NEWBRY XSAT:ODI XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges MBGPF:USA MOB:Sweden

Address Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51

Website https://www.mobergpharma.se

Moberg Pharma AB is a Swedish pharmaceutical company which develops and commercializes proprietary pharmaceuticals based on proven substances. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.

60GF Score

Get the complete analysis for FRA:MB8

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.80

Price

€1.06

GF Value

View FRA:MB8 Analysis

See Dividends per Share data for all stocks →